J Physiol Paris 93:479485 Sikiric P, Seiwerth S, Brcic L, Blagaic AB, Zoricic I, Sever M, Klicek R, Radic B, Keller N, Sipos K et al (2006) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
Epidemiology 22 , 476485 (2011)
Growth Factor Upregulation Rodent studies have shown increases in VEGF (vascular endothelial growth factor) expression in healing tissue following BPC-157 administration
Or are there discussions about the quality of the lyophilization, the solubility of the powder, or technical questions about its use in a research setting